Financial statements Farmak International
Balance sheet data of FARMAK INTERNATIONAL
|
Year
|
2017
|
2018
|
2019
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 47 738 049,54 | 40 456 812,01 | 34 573 845,09 | 29 921 518,15 | 33 454 076,79 | 38 992 748,92 |
| A. Fixed assets | 9 106 670,76 | 11 182 882,42 | 8 729 208,34 | 4 839 648,30 | 3 455 525,88 | 3 609 605,64 |
| B. Current assets | 38 631 378,78 | 29 273 929,59 | 25 844 636,75 | 25 081 869,85 | 29 998 550,91 | 35 383 143,28 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 47 738 049,54 | 40 456 812,01 | 34 573 845,09 | 29 921 518,15 | 33 454 076,79 | 38 992 748,92 |
| A. Equity | 17 372 716,12 | 3 033 747,52 | 3 914 656,87 | 8 103 069,61 | 13 426 397,49 | 16 783 965,72 |
| B. Liabilities and provisions for liabilities | 30 365 333,42 | 37 423 064,49 | 30 659 188,22 | 21 818 448,54 | 20 027 679,30 | 22 208 783,20 |
| I. Long-term liabilities | 0,00 | 6 049 923,20 | 4 523 110,28 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 29 043 778,94 | 29 925 018,72 | 24 859 313,11 | 20 274 054,74 | 18 675 810,15 | 19 864 089,24 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.